findmyKOL
Clinical trialNCT00528697CompletedPhase 2Interventional

A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

SponsorAbbVie (prior sponsor, Abbott)Enrollment278Attention-Deficit/Hyperactivity Disorder
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Site Reference Id/investigator# 5999

    Little Rock, Arkansas, United States

  • Site Reference Id/investigator# 5979

    El Centro, California, United States

  • Site Reference Id/investigator# 5986

    Boulder, Colorado, United States

  • Site Reference Id/investigator# 5993

    Bradenton, Florida, United States

  • Site Reference Id/investigator# 5995

    Jacksonville, Florida, United States

  • Site Reference Id/investigator# 5977

    Orlando, Florida, United States

  • Site Reference Id/investigator# 5981

    Northbrook, Illinois, United States

  • Site Reference Id/investigator# 5982

    Overland Park, Kansas, United States

  • Site Reference Id/investigator# 5992

    Omaha, Nebraska, United States

  • Site Reference Id/investigator# 5997

    Las Vegas, Nevada, United States

  • Site Reference Id/investigator# 5987

    Clementon, New Jersey, United States

  • Site Reference Id/investigator# 5996

    Eugene, Oregon, United States

  • Site Reference Id/investigator# 5984

    Portland, Oregon, United States

  • Site Reference Id/investigator# 5980

    Salem, Oregon, United States

  • Site Reference Id/investigator# 5994

    Charleston, South Carolina, United States

  • Site Reference Id/investigator# 5976

    Memphis, Tennessee, United States

  • Site Reference Id/investigator# 6000

    Austin, Texas, United States

  • Site Reference Id/investigator# 5998

    Herndon, Virginia, United States

  • Site Reference Id/investigator# 5978

    Bellevue, Washington, United States

  • Site Reference Id/investigator# 5983

    Middleton, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2007
Primary completion
30 Apr 2008
Completion
30 Apr 2008
Last update posted
29 Jan 2013
Registered enrollment
278
Registry id
NCT00528697

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.